Tabela 1D. miRNAs diferencialmente expressos no soro de pacientes com endometriose e pacientes controle.
miRNA | Regulação | Endometriose n | Controle n | Referências |
---|---|---|---|---|
let-7b | RN | 24 | 24 | Cho et al.(48) |
let-7b-5p | RN | 20 | 26 | Nematian et al.(49) |
miR-122 | RP | 60 | 25 | Wang et al.(19) |
miR-122 | RP | 45 | 35 | Maged et al.(50) |
miR-125b-5p | RP | 24 | 24 | Cosar et al.(51) |
miR-125b | RP | 20 | 26 | Nematian et al.(49) |
miR-127-3p | RN | 30 | 20 | Wang et al.(52) |
miR-135a | RN | 24 | 24 | Cosar et al.(51) |
miR-141 | RN | 60 | 25 | Wang et al.(19) |
miR-143-3p | RP | 24 | 24 | Cosar et al.(51) |
miR-145 | RN | 60 | 25 | Wang et al.(19) |
miR-145-5p | RP | 24 | 24 | Cosar et al.(51) |
miR-150-5p | RP | 24 | 24 | Cosar et al.(51) |
miR-15b-5p | RN | 30 | 20 | Wang et al.(52) |
miR-17 | RN | 80 | 60 | Wang et al.(53) |
miR-185-5p | RP | 30 | 20 | Wang et al.(52) |
miR-18a-5p | RP | 24 | 24 | Cosar et al.(51) |
miR-191 | RP | 12 | 12 | Dong et al.(35) |
miR-199a | RP | 60 | 25 | Wang et al.(19) |
miR-199a | RP | 45 | 35 | Maged et al.(50) |
miR-199a-5p | RN | 40 | 25 | Hsu et al.(54) |
miR-20a-5p | RN | 30 | 20 | Wang et al.(52) |
miR-30c-5p | RN | 30 | 20 | Wang et al.(52) |
miR-342-3p | RP | 24 | 24 | Cosar et al.(51) |
miR-3613-5p | RN | 24 | 24 | Cosar et al.(51) |
miR-370 | RN | 20 | 26 | Hu et al.(55) |
miR-424-3p | RP | 30 | 20 | Wang et al.(52) |
miR-451a | RP | 41 | 40 | Nothnick et al.(47) |
miR-451a | RP | 24 | 24 | Cosar et al.(51) |
miR-500a-3p | RP | 24 | 24 | Cosar et al.(51) |
miR-542-3p | RN | 60 | 25 | Wang et al.(19) |
miR-6755-3p | RN | 24 | 24 | Cosar et al.(51) |
miR-9 | RN | 60 | 25 | Wang et al.(19) |
miR-99b-5p | RN | 30 | 20 | Wang et al.(52) |
miRNA: microRNA; RN: regulação negativa; RP: regulação positiva.